Ascentage Pharma Group International

Insider activity at Ascentage Pharma shows cautious optimism: stable holdings, long‑term vesting tied to clinical milestones, and rising social‑media buzz hint at upcoming breakthroughs.

Ascentage Pharma’s CEO keeps a steady stake amid fresh insider trades and upcoming AACR pre‑clinical talks, hinting at growing confidence and potential upside.